Drug Shortage Report for MYLAN-HYDROXYUREA

Last updated on 2018-02-28 History
Report ID 3372
Drug Identification Number 02242920
Brand name MYLAN-HYDROXYUREA
Common or Proper name HYDROXYUREA
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) HYDROXYUREA
Strength(s) 500MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100BT
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-07-21
Actual start date 2017-07-24
Estimated end date 2018-02-26
Actual end date 2018-02-27
Shortage status Resolved
Updated date 2018-02-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v49 2018-02-28 English Compare
v48 2018-02-27 French Compare
v47 2018-02-27 English Compare
v46 2018-02-23 French Compare
v45 2018-02-23 English Compare
v44 2018-02-09 French Compare
v43 2018-02-09 English Compare
v42 2018-02-05 French Compare
v41 2018-02-05 English Compare
v40 2018-02-02 French Compare
v39 2018-02-02 English Compare
v38 2018-01-08 French Compare
v37 2018-01-08 English Compare
v36 2018-01-02 French Compare
v35 2018-01-02 English Compare
v34 2017-12-30 English Compare
v33 2017-12-11 French Compare
v32 2017-12-11 English Compare
v31 2017-11-29 French Compare
v30 2017-11-29 English Compare

Showing 1 to 20 of 49